Answers are grounded in this paper and cite their sources.
Explores efficient modification of pyrrolo derivatives, suggesting new avenues for drug development.
Rh-catalyzed, P(III)-directed arene ortho C-H diarylation and monoalkylation reactions of 7-aryl-pyrrolo[2,3-d]pyrimidine derivatives have been developed. A series of structurally diverse diarylated and monoalkylated phosphoryl-substituted pyrrolo[2,3-d]pyrimidine derivatives were obtained in moderate to good yields. The broad substrate scopes, good functional group tolerance, and high site selectivity render this strategy well-suited for the late-stage structural modification of pyrrolo[2,3-d]pyrimidine-based natural products and pharmaceuticals. This protocol enriches the library of biologically privileged pyrrolo[2,3-d]pyrimidine derivatives for further pharmacological evaluation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: